Asset Classes

Free investment financial education

Language

Multilingual content from IBKR

Close Navigation
Learn more about IBKR accounts
2 Biotech Stocks For Your June 2023 Watchlist

2 Biotech Stocks For Your June 2023 Watchlist

Posted June 21, 2023 at 10:15 am
Joe Samuel
StockMarket.com

Biotech stocks to watch in the stock market now.

The biotechnology sector is an exciting and dynamic area within the broader healthcare industry. It primarily involves the application of biological systems, organisms, or derivatives to develop or manufacture novel products or technologies. These include everything from new drugs and therapies to innovative agricultural products. This makes it an integral part of several industries, including healthcare, agriculture, and the environment.

Biotech stocks represent companies in this sector. Most often those focused on the development and commercialization of novel medical treatments and diagnostics. Investing in biotech stocks can be highly lucrative. This is due to the significant profit potential if a company successfully develops a new drug or therapy. However, it’s important to note that these stocks can be quite volatile. The journey from initial research to FDA approval is long, uncertain, and expensive, and many promising treatments fail along the way.

Despite the risks, the biotech sector is continually attracting investment due to its potential for substantial returns and its crucial role in medical innovation. New developments in areas like gene editing, personalized medicine, and regenerative therapies are opening up new avenues for treatment and potentially enormous markets for successful companies. While investing in biotech stocks may not be for the faint-hearted, for those who understand the risks and have a long-term perspective, the biotech sector offers opportunities unlike any other. With this in mind, let’s look at two biotech stocks to watch in the stock market now.

Biotech Stocks To Watch Right Now

DICE Therapeutics (DICE Stock)

To begin, DICE Therapeutics Inc. (DICE) is a biotechnology company that operates at the cutting edge of drug discovery and development. They focus on advancing therapies for autoimmune diseases and cancers through their platform that targets intracellular protein-protein interactions.

Just this morning, Eli Lilly and Company (NYSE: LLY) announced plans to acquire DICE Therapeutics. In detail, Lilly is acquiring DICE Therapeutics for its novel oral therapeutic candidates and its proprietary DELSCAPE technology platform. This strategic acquisition, costing around $2.4 billion, is projected to enhance Eli Lilly’s immunology department by incorporating DICE’s innovative drug discovery technologies and workforce. The transaction has been approved by both companies boards of directors. Furthermore, the deal is pending to close in the third quarter of 2023 and will see all outstanding shares of DICE bought for $48 each.

Following this news release, shares of DICE stock surged on Tuesday morning by 37.31%, currently trading at $46.48 a share.

DICE Therapeutics (DICE Stock)

Source: TD Ameritrade TOS

Pfizer (PFE Stock)

Next, Pfizer Inc. (PFE) is one of the world’s largest pharmaceutical companies. It’s known globally for a wide range of products across different therapeutic areas. The company’s range of products encompasses treatments for cancer, immune disorders, and rare conditions, in addition to vaccines designed to combat infectious diseases.

This morning, Tuesday, Pfizer Inc. announced that it will host a webcast conference call with investment analysts at 10 a.m. EDT on Tuesday, August 1, 2023. This call, which is open to both investors and the general public, is going to provide an update on Pfizer’s performance based on its Second Quarter 2023 Performance Report. Moreover, the second quarter 2023 financial results will be released on the same day.

Meanwhile, during Tuesday’s mid-morning trading session, shares of PFE stock are trading slightly lower on the day so far by 1.04% at $39.66 a share.

Pfizer (PFE Stock)

Source: TD Ameritrade TOS

Originally Posted June 20, 2023 – 2 Biotech Stocks For Your June 2023 Watchlist

Join The Conversation

If you have a general question, it may already be covered in our FAQs. If you have an account-specific question or concern, please reach out to Client Services.

Leave a Reply

Disclosure: Interactive Brokers

Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from StockMarket.com and is being posted with its permission. The views expressed in this material are solely those of the author and/or StockMarket.com and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

IBKR Campus Newsletters

This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.